Related Experiment Video
Updated: Jun 12, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Opioids in the Brazilian Healthcare Landscape: Crucial Analysis through Anvisa VigiMed Data and Pharmacogenetic
Lariana Almeida Szczesny1, Raíssa Nunes Dos Santos1, Juliano de Oliveira Silveira1
1Programa de Pós-graduação em Biociências, Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA, Rio Grande do Sul, Porto Alegre 90050-170, Brazil.
Abstract:
Adverse Drug Reactions (ADRs) present a significant challenge to healthcare systems, contributing substantially to hospital admissions. Opioid analgesics are widely used in the pharmacological treatment of various types of pain; however, ADRs represent a major limitation to their use. This study aims to investigate the profile of ADRs reported in Vigimed (the official Brazilian ADR reporting system) following the implementation of active surveillance through pharmacovigilance trackers. Additionally, it evaluates pharmacogenetic evidence to identify genes potentially involved in opioid-related ADRs. This retrospective cross-sectional study analyzed ADR cases reported to Vigimed from January 2018 to April 2023. Data were extracted from Vigimed, tabulated, and subjected to statistical analysis, using the reporting odds ratio (ROR) to assess the strength of associations between opioids and ADRs. During the study period, there were 238,363 ADR reports, of which 6,001 were related to opioid treatment. The distribution among opioids was as follows: 36.7% morphine, 32.4% tramadol, 21.6% fentanyl, 5.4% methadone, 3.7% codeine, and 0.2% oxycodone. The most frequent adverse events associated with opioids were cardiac disorders (ROR 1.70), skin and subcutaneous tissue disorders (ROR 2.18), gastrointestinal disorders (ROR 2.88), and nervous system disorders (ROR 1.19). Furthermore, pharmacogenetic evidence indicates that the CYP2D6 gene has a Level 1 association for codeine and tramadol and a Level 2 association for oxycodone. These findings highlight significant associations between specific opioids and ADRs, emphasizing the influence of genetic variations on adverse reactions and the need for personalized medicine in pain management.
More Related Videos
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Regulation
Opioid Receptors: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

